Evidence map›Paper›PMID 34816387›Full record

ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2022

Characterization and cytotoxicity assessment of biosurfactant derived from Lactobacillus pentosus NCIM 2912.

Vikrant Sharma, Deepti Singh, Mehak Manzoor, Arun G Banpurkar, Surekha K Satpute, Deepansh Sharma

Abstract read
In one paragraph

Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Terrestrial bacterial isolate capability of producing surface-active biosurfactant: genetic identification, biochemical and morphological approach.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article
  2. VaginalBiofilm · 2025
    Article
  3. Article
  4. Production of biosurfactant byJournal of environmental health science & engineering · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Vikrant Sharma *Amity Institute of Microbial Technology, Amity University Rajasthan, Jaipur, Rajasthan, 303002, India.
Deepti Singh *Amity Institute of Microbial Technology, Amity University Rajasthan, Jaipur, Rajasthan, 303002, India.
Mehak ManzoorAmity Institute of Microbial Technology, Amity University Rajasthan, Jaipur, Rajasthan, 303002, India.
Arun G BanpurkarDepartment of Physics, Savitribai Phule Pune University, Pune, 411007, India.
Surekha K SatputeDepartment of Microbiology, Savitribai Phule Pune University, Pune, 411007, India. drsurekhasatpute@gmail.com.
Deepansh SharmaAmity Institute of Microbial Technology, Amity University Rajasthan, Jaipur, Rajasthan, 303002, India. deepanshsharma@gmail.com.ORCID http://orcid.org/0000-0001-6603-2812

Funding

Rashtriya Uchchattar Shiksha Abhiyan RUSA-CBS-TH- 3.2
6 · The paper itself

Abstract

Noteworthy properties of biosurfactant (BS) are fascinating scientific fraternity to explore them for food, medicinal, cosmetic, or pharmaceutical etc. applications. Newer products intended for pharmaceutical purposes are mandatory to go through pragmatic evaluation protocols. BS, being less cytotoxic, offers an ideal candidature for widespread applications in the healthcare sector. The goal of the current study was the isolation, physico-chemical characterization, and safety assessment of cell-associated biosurfactant (CABS) from Lactobacillus pentosus NCIM 2912. The culture was grown in a 3-L fermentor to produce CABS from the cell pellets through procedures like centrifugation, filtration, dialysis, column chromatography, and freeze-drying. Further, physical properties like surface tension (ST), critical micelle concentration (CMC), contact angle (CA), emulsification activity, stability of emulsion (height of emulsion, the extent of coalescence, and appearance), and ionic character of CABS were evaluated. Analytical characterization through TLC, FTIR, NMR, and GC-MS was carried out. The physico-chemical characterization revealed CABS as an anionic, multicomponent glycolipopeptide having a hydrophobic chain comprising butanoic acid (C4), decanoic acid (C10), undecanoic acid (C11), tridecanoic acid (C13), hexadecenoic acid (C16), and octadecanoic acid (C18). The oil-in-water (O/W) emulsions formed by CABS with various oils (olive, sesame, soybean, coconut) were stabilized up to the 7th day of storage and were analogous with polysorbate 80 (emulsifier/defoamer used in food industries). The O/W emulsions are quite stable at room temperature with no evidence of coalescence of droplets around 1 week. The cytotoxicity of CABS was evaluated through MTT (3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide) assay. Cytotoxicity study performed on the human embryonic kidney (HEK 293), mouse fibroblast ATCC L929 and human epithelial type (HEP-2) cell lines recorded viability of 90.3 ± 0.1%, 99.2 ± 0.43, and 94.3 ± 0.2% respectively. The toxicity of the BS was comparable to that of the commercially used rhamnolipid sample. Thus, CABS derived from L. pentosus NCIM 2912 pose promising applications in the pharmaceutical, food industries acquiescently. The multifunctional potential of the incredibly versatile microbial product like BS from lactic acid bacteria (LAB) certainly contributes to wider avenues for varied industries.

Indexed as

Lactiplantibacillus pentosusAnimalsEmulsifying AgentsEmulsionsHEK293 CellsHumansMiceSurface-Active AgentsEmulsifying AgentsEmulsionsSurface-Active AgentsApplicationsBioemulsifiersBiosurfactantsCytotoxicityEmulsificationGlycolipopeptide

Identifiers

PMID34816387
PMCPMC8882494

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.